DE69131181D1 - Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulation - Google Patents
Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulationInfo
- Publication number
- DE69131181D1 DE69131181D1 DE69131181T DE69131181T DE69131181D1 DE 69131181 D1 DE69131181 D1 DE 69131181D1 DE 69131181 T DE69131181 T DE 69131181T DE 69131181 T DE69131181 T DE 69131181T DE 69131181 D1 DE69131181 D1 DE 69131181D1
- Authority
- DE
- Germany
- Prior art keywords
- subpopulation
- cell population
- subset
- interest
- separated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000126 substance Substances 0.000 abstract 5
- 238000003149 assay kit Methods 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0085—Mossbauer effect therapy based on mossbauer effect of a material, i.e. re-emission of gamma rays after absorption of gamma rays by the material; selective radiation therapy, i.e. involving re-emission of ionizing radiation upon exposure to a first ionizing radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/619,838 US5385822A (en) | 1988-05-02 | 1990-11-29 | Methods for detection and quantification of cell subsets within subpopulations of a mixed cell population |
PCT/US1991/008235 WO1992009894A1 (en) | 1990-11-29 | 1991-11-05 | Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69131181D1 true DE69131181D1 (de) | 1999-06-02 |
DE69131181T2 DE69131181T2 (de) | 1999-11-04 |
Family
ID=24483517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69131181T Expired - Fee Related DE69131181T2 (de) | 1990-11-29 | 1991-11-05 | Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulation |
Country Status (8)
Country | Link |
---|---|
US (1) | US5385822A (de) |
EP (1) | EP0559738B1 (de) |
JP (1) | JPH06503643A (de) |
AT (1) | ATE179520T1 (de) |
AU (1) | AU667031B2 (de) |
CA (1) | CA2095237A1 (de) |
DE (1) | DE69131181T2 (de) |
WO (1) | WO1992009894A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2593192A (en) | 1992-09-14 | 1994-04-12 | Oystein Fodstad | Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations |
US5656499A (en) * | 1994-08-01 | 1997-08-12 | Abbott Laboratories | Method for performing automated hematology and cytometry analysis |
US5631165A (en) * | 1994-08-01 | 1997-05-20 | Abbott Laboratories | Method for performing automated hematology and cytometry analysis |
US5891734A (en) * | 1994-08-01 | 1999-04-06 | Abbott Laboratories | Method for performing automated analysis |
US5792617A (en) * | 1994-08-18 | 1998-08-11 | Rotman; M. Boris | Cell proliferation-based amplified detection of analytes |
US5658745A (en) * | 1995-02-17 | 1997-08-19 | E. I. Du Pont De Nemours And Company | Cell enumeration immunoassay |
US5876956A (en) * | 1995-05-15 | 1999-03-02 | Johns Hopkins University School Of Medicine | Methods for identification or purification of cells containing an enzymatic intracellular marker |
US5840859A (en) * | 1995-07-06 | 1998-11-24 | Research Corporation Technologies, Inc. | (Aminostyryl)pyridinium compounds for radiolabelling cell membranes |
ATE496288T1 (de) | 1995-10-11 | 2011-02-15 | Luminex Corp | Gleichzeitige mehrfachanalyse klinischer proben |
US5981180A (en) * | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
US5736330A (en) * | 1995-10-11 | 1998-04-07 | Luminex Corporation | Method and compositions for flow cytometric determination of DNA sequences |
EP1019546B1 (de) * | 1996-03-26 | 2004-12-15 | Cylex, Inc. | Verfahren zur messung der lymphozytenfunktion |
US6449562B1 (en) | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
EP0963554B1 (de) * | 1997-01-30 | 2002-10-23 | MERCK PATENT GmbH | Verfahren zur immunologischen bestimmung eines analyten |
US7169571B2 (en) | 1997-09-12 | 2007-01-30 | Cylex, Inc. | Methods for measurement of lymphocyte function |
US6193892B1 (en) | 1999-03-03 | 2001-02-27 | Promega Corporation | Magnetic separation assembly and method |
GB2368909B (en) * | 2000-11-09 | 2004-09-22 | Amersham Pharm Biotech Uk Ltd | Separation particles |
WO2002044695A1 (en) * | 2000-11-16 | 2002-06-06 | Burstein Technologies, Inc. | Methods and apparatus for detecting and quantifying lymphocytes with optical biodiscs |
CN1488073A (zh) * | 2001-04-17 | 2004-04-07 | 西莱克斯公司 | 利用促细胞分裂原和抗原测定淋巴细胞活化的方法 |
EP1405073B1 (de) * | 2001-07-11 | 2010-03-03 | National Health Laboratory Service | Bestimmung der zellanzahl |
US20030129665A1 (en) * | 2001-08-30 | 2003-07-10 | Selvan Gowri Pyapali | Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems |
US20030143637A1 (en) * | 2001-08-31 | 2003-07-31 | Selvan Gowri Pyapali | Capture layer assemblies for cellular assays including related optical analysis discs and methods |
JP2005502872A (ja) * | 2001-09-07 | 2005-01-27 | バースタイン テクノロジーズ,インコーポレイティド | 光バイオディスクシステムを使用した、核の形態に基づく白血球の型の識別および定量 |
US7157049B2 (en) * | 2001-11-20 | 2007-01-02 | Nagaoka & Co., Ltd. | Optical bio-discs and fluidic circuits for analysis of cells and methods relating thereto |
US20040058333A1 (en) * | 2002-09-23 | 2004-03-25 | Bell Michael L. | Assay products and procedures |
US7326573B2 (en) * | 2003-01-10 | 2008-02-05 | Beckman Coulter, Inc. | Assay procedures and apparatus |
EP1836490A2 (de) * | 2004-12-14 | 2007-09-26 | University Of The Witwatersrand Johannesburg | Verfahren zur diagnose und beobachtung zellulärer krankheitsreservoirs |
KR102031347B1 (ko) * | 2018-12-17 | 2019-11-08 | 서울대학교산학협력단 | 저온유통식품의 온도 모니터링을 위한 시간-온도 지시기 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3970518A (en) * | 1975-07-01 | 1976-07-20 | General Electric Company | Magnetic separation of biological particles |
US4157323A (en) * | 1976-06-09 | 1979-06-05 | California Institute Of Technology | Metal containing polymeric functional microspheres |
GB1572220A (en) * | 1976-10-07 | 1980-07-30 | Mochida Pharm Co Ltd | Immunochemical process of measuring physiologically active substances |
US4219411A (en) * | 1978-09-18 | 1980-08-26 | California Institute Of Technology | Cell sorting apparatus |
US4230685A (en) * | 1979-02-28 | 1980-10-28 | Northwestern University | Method of magnetic separation of cells and the like, and microspheres for use therein |
US4284412A (en) * | 1979-07-13 | 1981-08-18 | Ortho Diagnostics, Inc. | Method and apparatus for automated identification and enumeration of specified blood cell subclasses |
US4582797A (en) * | 1980-09-25 | 1986-04-15 | The Salk Institute For Biological Studies | Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins |
US4532203A (en) * | 1982-10-26 | 1985-07-30 | Syva Company | Fluorescent determination of microlymphocytotoxicity |
US4677067A (en) * | 1984-06-22 | 1987-06-30 | Bio-Magnetech Corporation | Magnetotactic bacteria in clinical assay, immunoassay, and cell separation procedures and the like |
US4748129A (en) * | 1984-08-28 | 1988-05-31 | Snytex (U.S.A.) Inc. | Assay method employing fluorescent cell incorporative dye |
US4727020A (en) * | 1985-02-25 | 1988-02-23 | Becton, Dickinson And Company | Method for analysis of subpopulations of blood cells |
US4666595A (en) * | 1985-09-16 | 1987-05-19 | Coulter Electronics, Inc. | Apparatus for acoustically removing particles from a magnetic separation matrix |
US4710472A (en) * | 1985-09-25 | 1987-12-01 | The United States Of America As Represented By The Secretary Of The Navy | Magnetic separation device |
DE3541033A1 (de) * | 1985-11-19 | 1987-05-21 | Boehringer Mannheim Gmbh | Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz |
FR2621128B1 (fr) * | 1987-09-30 | 1994-05-06 | Sanofi | Trousse et methode de dosage immunometrique applicables a des cellules entieres |
US4978625A (en) * | 1987-10-19 | 1990-12-18 | Becton, Dickinson And Company | Fluorescence immunoassay using water insoluble dyes |
US5085985A (en) * | 1987-11-12 | 1992-02-04 | Becton Dickinson & Co. | Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells |
US5256532A (en) * | 1988-05-02 | 1993-10-26 | Zynaxis Technologies, Inc. | Methods, reagents and test kits for determination of subpopulations of biological entities |
IL91414A0 (en) * | 1988-08-31 | 1990-04-29 | Zynaxis Technologies Inc | Reagents and methods for the determination of analytes |
CA1339840C (en) * | 1988-12-16 | 1998-04-28 | Kenneth Kortright | Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics |
FR2644893B1 (fr) * | 1989-03-24 | 1991-07-12 | Sanofi Sa | Trousse et methode de dosage applicables a des cellules entieres |
FR2644894B1 (fr) * | 1989-03-24 | 1994-05-13 | Sanofi | Trousse et methode de dosage enzymatique applicables a des cellules entieres |
-
1990
- 1990-11-29 US US07/619,838 patent/US5385822A/en not_active Expired - Fee Related
-
1991
- 1991-11-05 AT AT92900356T patent/ATE179520T1/de not_active IP Right Cessation
- 1991-11-05 DE DE69131181T patent/DE69131181T2/de not_active Expired - Fee Related
- 1991-11-05 JP JP4501274A patent/JPH06503643A/ja active Pending
- 1991-11-05 CA CA002095237A patent/CA2095237A1/en not_active Abandoned
- 1991-11-05 WO PCT/US1991/008235 patent/WO1992009894A1/en active IP Right Grant
- 1991-11-05 AU AU90376/91A patent/AU667031B2/en not_active Ceased
- 1991-11-05 EP EP92900356A patent/EP0559738B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH06503643A (ja) | 1994-04-21 |
EP0559738A1 (de) | 1993-09-15 |
EP0559738B1 (de) | 1999-04-28 |
ATE179520T1 (de) | 1999-05-15 |
DE69131181T2 (de) | 1999-11-04 |
EP0559738A4 (en) | 1994-09-14 |
WO1992009894A1 (en) | 1992-06-11 |
CA2095237A1 (en) | 1992-05-30 |
AU9037691A (en) | 1992-06-25 |
US5385822A (en) | 1995-01-31 |
AU667031B2 (en) | 1996-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69131181D1 (de) | Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulation | |
DE69618350D1 (de) | Ein verfahren zum nachweis biologisch aktiver substanzen | |
SE9903988D0 (sv) | Method of analysis | |
US6861230B1 (en) | Antibiotic sensitivity testing | |
DE69032854T2 (de) | Verfahren, reagenzien und testkits zum nachweis von subpopulationen biologischer substanzen | |
DE60039072D1 (de) | Verfahren zum screenen von mehrfach transformierteon von fluoreszenzproteinen | |
CA2121506A1 (en) | Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same | |
DK463089D0 (da) | Fremgangsmaade og reagenssaet til detektion af en specifik nucleinsyresekvens i en proeve indeholdende en nucleinsyre | |
DE69718268D1 (de) | Verfahren zur Detektion von Zielnukleinsäure, Verfahren zu ihrer Quantifizierung und Pyrylium-Verbindungen zur Chemilumineszenz-Analyse | |
ATE408829T1 (de) | Verfahren und assaykits zum nachweis mononuklearer zellphänotypen | |
ATE215993T1 (de) | Nachweis von nukleinsäuren mit breitem dynamikbereich unter verwendung von aggregat- primer-reihen | |
ATE35693T1 (de) | Verfahren und vorrichtung zur identifizierung von mikroorganismen. | |
ATE354800T1 (de) | Verfahren zum nachweiss von antikörpern in einer probe | |
DE69033352T2 (de) | Competitives enzym-testverfahren zum nachweis von phosphothioaten | |
ATE295537T1 (de) | Testverfahren zum nachweiss von lipoproteinen | |
Melnicoff et al. | Methods for detection and quantification of cell subsets within subpopulations of a mixed cell population | |
DK0507904T3 (da) | Fremgangsmåde til vurdering af tilstrækkeligheden af kliniske prøver til hybridiseringsassays og kit til udførelse af vurde | |
ATE347108T1 (de) | Zusammensetzungen und verfahren zum bestimmen von aa4rp | |
GB2348438A (en) | Detecting microbes by bioluminescence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: INTRACEL CORP., ISSAGUAH, WASH., US |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |